Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mark Petrash

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
Biochemistry|March 27, 2002
Alteration of substrate selectivity through mutation of two arginine residues in the binding site of amadoriase II from Aspergillus spXinle Wu, Shu G Chen, J Mark Petrash, et al.
Biochimica Et Biophysica Acta|December 5, 2006
Functional studies of aldo-keto reductases in Saccharomyces cerevisiaeQing Chang, Terry A Griest, Theresa M Harter, et al.
Chemico-Biological Interactions|December 3, 2014
Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cellsKun-Che Chang, Anson Snow, Daniel V LaBarbera, et al.
Investigative Ophthalmology & Visual Science|March 29, 2014
Aldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microgliaKun-Che Chang, Jessica Ponder, Daniel V Labarbera, et al.
Acta Ophthalmologica Scandinavica|March 17, 2007
Comment on: the Stokes-Einstein equation and the physiological effects of vitreous surgeryKelly A Barton, Ying-Bo Shui, J Mark Petrash, et al.
Asia Pacific Journal of Clinical Nutrition|December 31, 2008
Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complicationsMegha Saraswat, P Muthenna, P Suryanarayana, et al.
Molecular Pharmaceutics|October 18, 2013
Nanoparticles in porous microparticles prepared by supercritical infusion and pressure quench technology for sustained delivery of bevacizumabSarath K Yandrapu, Arun K Upadhyay, J Mark Petrash, et al.
Plos One|April 25, 2013
Deletion of aldose reductase from mice inhibits diabetes-induced retinal capillary degeneration and superoxide generationJie Tang, Yunpeng Du, J Mark Petrash, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2022
Nano-assemblies enhance chaperone activity, stability, and delivery of alpha B-crystallin-D3 (αB-D3)Arun K Upadhyay, Niklaus H Mueller, J Mark Petrash, et al.
IUBMB Life|September 14, 2010
Importance of eye lens α-crystallin heteropolymer with 3:1 αA to αB ratio: stability, aggregation, and modificationsPasumarthi Srinivas, Akkaladevi Narahari, J Mark Petrash, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Biochemistry|March 27, 2002
Alteration of substrate selectivity through mutation of two arginine residues in the binding site of amadoriase II from Aspergillus spXinle Wu, Shu G Chen, J Mark Petrash, et al.
Biochimica Et Biophysica Acta|December 5, 2006
Functional studies of aldo-keto reductases in Saccharomyces cerevisiaeQing Chang, Terry A Griest, Theresa M Harter, et al.
Chemico-Biological Interactions|December 3, 2014
Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cellsKun-Che Chang, Anson Snow, Daniel V LaBarbera, et al.
Investigative Ophthalmology & Visual Science|March 29, 2014
Aldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microgliaKun-Che Chang, Jessica Ponder, Daniel V Labarbera, et al.
Acta Ophthalmologica Scandinavica|March 17, 2007
Comment on: the Stokes-Einstein equation and the physiological effects of vitreous surgeryKelly A Barton, Ying-Bo Shui, J Mark Petrash, et al.
Asia Pacific Journal of Clinical Nutrition|December 31, 2008
Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complicationsMegha Saraswat, P Muthenna, P Suryanarayana, et al.
Molecular Pharmaceutics|October 18, 2013
Nanoparticles in porous microparticles prepared by supercritical infusion and pressure quench technology for sustained delivery of bevacizumabSarath K Yandrapu, Arun K Upadhyay, J Mark Petrash, et al.
Plos One|April 25, 2013
Deletion of aldose reductase from mice inhibits diabetes-induced retinal capillary degeneration and superoxide generationJie Tang, Yunpeng Du, J Mark Petrash, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 22, 2022
Nano-assemblies enhance chaperone activity, stability, and delivery of alpha B-crystallin-D3 (αB-D3)Arun K Upadhyay, Niklaus H Mueller, J Mark Petrash, et al.
IUBMB Life|September 14, 2010
Importance of eye lens α-crystallin heteropolymer with 3:1 αA to αB ratio: stability, aggregation, and modificationsPasumarthi Srinivas, Akkaladevi Narahari, J Mark Petrash, et al.
Pageof 9